Assessment of Pulmonary Vein Diameters in Cavalier King Charles Spaniels with Myxomatous Mitral Valve Disease

The present study aimed to compare pulmonary vein (PV) diameters between Cavalier King Charles Spaniels (CKCSs) with myxomatous mitral valve disease (MMVD) and healthy CKCSs, assess correlations between PV diameters and echocardiographic parameters, and identify the optimal PV diameter cut-off value...

Full description

Saved in:
Bibliographic Details
Main Authors: Carlotta Ferri, Juliette Besso, Hugues Gaillot, Yannick Ruel, Albert Agoulon, Christophe Bourguignon, Clémence Mey, Vassiliki Gouni
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Veterinary Sciences
Subjects:
Online Access:https://www.mdpi.com/2306-7381/12/7/615
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850071865220923392
author Carlotta Ferri
Juliette Besso
Hugues Gaillot
Yannick Ruel
Albert Agoulon
Christophe Bourguignon
Clémence Mey
Vassiliki Gouni
author_facet Carlotta Ferri
Juliette Besso
Hugues Gaillot
Yannick Ruel
Albert Agoulon
Christophe Bourguignon
Clémence Mey
Vassiliki Gouni
author_sort Carlotta Ferri
collection DOAJ
description The present study aimed to compare pulmonary vein (PV) diameters between Cavalier King Charles Spaniels (CKCSs) with myxomatous mitral valve disease (MMVD) and healthy CKCSs, assess correlations between PV diameters and echocardiographic parameters, and identify the optimal PV diameter cut-off value that distinguishes stage C from stage B2. CKCSs were recruited both retrospectively and prospectively and classified according to the ACVIM guidelines (stages A, B1, B2, and C). From a left apical view, the diameters of three PVs (PV1, PV2, and PV3) were measured with high reproducibility. In healthy dogs, the PV2 diameter showed no correlation with body weight. The PV2 diameter was significantly higher in stage B2 compared to B1 and in stage C compared to B2, while no difference was found between stages A and B1. The median (IQR) PV2 diameters were 4.9 mm (3.9–5.2) in stage A, 5.1 mm (4.0–6.0) in stage B1, 9.3 mm (7.3–11.1) in stage B2, and 13.7 mm (9.9–15.1) in stage C. Positive correlations were observed between the PV2 diameter and the left ventricular internal diameter normalized for body weight, the left atrium-to-aorta ratio, mitral E wave peak velocity, tricuspid regurgitation pressure gradient, and regurgitant fraction. A PV2 diameter cut-off value of 12.8 mm discriminated stage C from stage B2 with 57% sensitivity and 93% specificity. The PV2 diameter is a reproducible echocardiographic measure that increases with MMVD severity and could assist in the early detection of congestive heart failure. However, the modest sensitivity observed reflects the overlap of PV2 measurements between stages B2 and C. Therefore, PV2 should be interpreted with caution and considered a supportive, rather than exclusive, tool in disease staging and therapeutic decision-making.
format Article
id doaj-art-8d456d29ce3c458db3fed717bdee8e7b
institution DOAJ
issn 2306-7381
language English
publishDate 2025-06-01
publisher MDPI AG
record_format Article
series Veterinary Sciences
spelling doaj-art-8d456d29ce3c458db3fed717bdee8e7b2025-08-20T02:47:13ZengMDPI AGVeterinary Sciences2306-73812025-06-0112761510.3390/vetsci12070615Assessment of Pulmonary Vein Diameters in Cavalier King Charles Spaniels with Myxomatous Mitral Valve DiseaseCarlotta Ferri0Juliette Besso1Hugues Gaillot2Yannick Ruel3Albert Agoulon4Christophe Bourguignon5Clémence Mey6Vassiliki Gouni7ADVETIA Veterinary Hospital, 9 Avenue Louis Breguet, 78140 Vélizy-Villacoublay, FranceVetradmobile, 97 Rue Monge, 75005 Paris, FranceADVETIA Veterinary Hospital, 9 Avenue Louis Breguet, 78140 Vélizy-Villacoublay, FranceADVETIA Veterinary Hospital, 9 Avenue Louis Breguet, 78140 Vélizy-Villacoublay, FranceOniris, INRAE, BIOEPAR, 101 Route de Gachet, 44300 Nantes, FranceADVETIA Veterinary Hospital, 9 Avenue Louis Breguet, 78140 Vélizy-Villacoublay, FranceADVETIA Veterinary Hospital, 9 Avenue Louis Breguet, 78140 Vélizy-Villacoublay, FranceADVETIA Veterinary Hospital, 9 Avenue Louis Breguet, 78140 Vélizy-Villacoublay, FranceThe present study aimed to compare pulmonary vein (PV) diameters between Cavalier King Charles Spaniels (CKCSs) with myxomatous mitral valve disease (MMVD) and healthy CKCSs, assess correlations between PV diameters and echocardiographic parameters, and identify the optimal PV diameter cut-off value that distinguishes stage C from stage B2. CKCSs were recruited both retrospectively and prospectively and classified according to the ACVIM guidelines (stages A, B1, B2, and C). From a left apical view, the diameters of three PVs (PV1, PV2, and PV3) were measured with high reproducibility. In healthy dogs, the PV2 diameter showed no correlation with body weight. The PV2 diameter was significantly higher in stage B2 compared to B1 and in stage C compared to B2, while no difference was found between stages A and B1. The median (IQR) PV2 diameters were 4.9 mm (3.9–5.2) in stage A, 5.1 mm (4.0–6.0) in stage B1, 9.3 mm (7.3–11.1) in stage B2, and 13.7 mm (9.9–15.1) in stage C. Positive correlations were observed between the PV2 diameter and the left ventricular internal diameter normalized for body weight, the left atrium-to-aorta ratio, mitral E wave peak velocity, tricuspid regurgitation pressure gradient, and regurgitant fraction. A PV2 diameter cut-off value of 12.8 mm discriminated stage C from stage B2 with 57% sensitivity and 93% specificity. The PV2 diameter is a reproducible echocardiographic measure that increases with MMVD severity and could assist in the early detection of congestive heart failure. However, the modest sensitivity observed reflects the overlap of PV2 measurements between stages B2 and C. Therefore, PV2 should be interpreted with caution and considered a supportive, rather than exclusive, tool in disease staging and therapeutic decision-making.https://www.mdpi.com/2306-7381/12/7/615caninemyxomatous mitral valve diseasepulmonary veinCavalier King Charles Spanielscongestive heart failure
spellingShingle Carlotta Ferri
Juliette Besso
Hugues Gaillot
Yannick Ruel
Albert Agoulon
Christophe Bourguignon
Clémence Mey
Vassiliki Gouni
Assessment of Pulmonary Vein Diameters in Cavalier King Charles Spaniels with Myxomatous Mitral Valve Disease
Veterinary Sciences
canine
myxomatous mitral valve disease
pulmonary vein
Cavalier King Charles Spaniels
congestive heart failure
title Assessment of Pulmonary Vein Diameters in Cavalier King Charles Spaniels with Myxomatous Mitral Valve Disease
title_full Assessment of Pulmonary Vein Diameters in Cavalier King Charles Spaniels with Myxomatous Mitral Valve Disease
title_fullStr Assessment of Pulmonary Vein Diameters in Cavalier King Charles Spaniels with Myxomatous Mitral Valve Disease
title_full_unstemmed Assessment of Pulmonary Vein Diameters in Cavalier King Charles Spaniels with Myxomatous Mitral Valve Disease
title_short Assessment of Pulmonary Vein Diameters in Cavalier King Charles Spaniels with Myxomatous Mitral Valve Disease
title_sort assessment of pulmonary vein diameters in cavalier king charles spaniels with myxomatous mitral valve disease
topic canine
myxomatous mitral valve disease
pulmonary vein
Cavalier King Charles Spaniels
congestive heart failure
url https://www.mdpi.com/2306-7381/12/7/615
work_keys_str_mv AT carlottaferri assessmentofpulmonaryveindiametersincavalierkingcharlesspanielswithmyxomatousmitralvalvedisease
AT juliettebesso assessmentofpulmonaryveindiametersincavalierkingcharlesspanielswithmyxomatousmitralvalvedisease
AT huguesgaillot assessmentofpulmonaryveindiametersincavalierkingcharlesspanielswithmyxomatousmitralvalvedisease
AT yannickruel assessmentofpulmonaryveindiametersincavalierkingcharlesspanielswithmyxomatousmitralvalvedisease
AT albertagoulon assessmentofpulmonaryveindiametersincavalierkingcharlesspanielswithmyxomatousmitralvalvedisease
AT christophebourguignon assessmentofpulmonaryveindiametersincavalierkingcharlesspanielswithmyxomatousmitralvalvedisease
AT clemencemey assessmentofpulmonaryveindiametersincavalierkingcharlesspanielswithmyxomatousmitralvalvedisease
AT vassilikigouni assessmentofpulmonaryveindiametersincavalierkingcharlesspanielswithmyxomatousmitralvalvedisease